Immunohistochemical staining of prostate cancer tissues further revealed that TDO2 protein levels were substantially higher in CRPC and high-grade adenocarcinomas than in low-grade adenocarcinomas (Fig. 3d). The gene discussed is TDO2; the disease is prostate carcinoma.